Journal of Tuberculosis and Lung Disease ›› 2026, Vol. 7 ›› Issue (1): 59-72.doi: 10.19983/j.issn.2096-8493.20250104
• Original Articles • Previous Articles Next Articles
Li Yue1, Liu Keliang2, Lyu Xiangpei2, Wang Huanqiang2(
)
Received:2025-07-22
Online:2026-02-20
Published:2026-02-09
Contact:
Wang Huanqiang, Email: Supported by:CLC Number:
Li Yue, Liu Keliang, Lyu Xiangpei, Wang Huanqiang. Bibliometric analysis of research hotspots and trends in silicosis fibrosis[J]. Journal of Tuberculosis and Lung Disease , 2026, 7(1): 59-72. doi: 10.19983/j.issn.2096-8493.20250104
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.20250104
| 顺位 | 研究学科(WoS categories) | 发文量(篇) |
|---|---|---|
| 1 | 毒理学(toxicology) | 217 |
| 2 | 药理学与药学(pharmacology & pharmacy) | 131 |
| 3 | 呼吸系统(respiratory system) | 122 |
| 4 | 公共、环境与职业健康(public, environmental & occupational health) | 120 |
| 5 | 环境科学(environmental sciences) | 111 |
| 6 | 医学研究与实验(medicine, research & experimental) | 97 |
| 7 | 生物化学与分子生物学(biochemistry & molecular biology) | 90 |
| 8 | 细胞生物学(cell biology) | 76 |
| 9 | 免疫学(immunology) | 64 |
| 10 | 交叉科学(multidisciplinary sciences) | 43 |
| 顺位 | 期刊名称 | 发文量(篇) | 被引频次 | 影响因子(2024年) |
|---|---|---|---|---|
| 1 | Ecotoxicology and Environmental Safety | 44 | 578 | 6.1 |
| 2 | International Immunopharmacology | 26 | 278 | 4.7 |
| 3 | Toxicology Letters | 26 | 574 | 2.9 |
| 4 | International Journal of Molecular Sciences | 25 | 595 | 4.9 |
| 5 | Toxicology and Applied Pharmacology | 19 | 521 | 3.4 |
| 6 | American Journal of Industrial Medicine | 16 | 220 | 3.1 |
| 7 | Plos One | 16 | 772 | 2.6 |
| 8 | Scientific Reports | 16 | 508 | 3.9 |
| 9 | Occupational and Environmental Medicine | 13 | 361 | 3.1 |
| 10 | Biomedicine and Pharmacology | 12 | 211 | 7.5 |
| 顺位 | 题目 | 第一作者 | 出现 时间 | 突现 强度 | 突现开 始年份 | 突现结 束年份 | 2000—2025年 |
|---|---|---|---|---|---|---|---|
| 1 | Basic pathogenetic mechanisms in silicosis: current understanding | Rimal B | 2005 | 8.91 | 2007 | 2010 | ![]() |
| 2 | Silica binding and toxicity in alveolar macrophages | Hamilton RF Jr | 2008 | 10.48 | 2009 | 2013 | ![]() |
| 3 | The Nalp3 inflammasome is essential for the development of silicosis. | Cassel SL | 2008 | 8.18 | 2010 | 2013 | ![]() |
| 4 | Silicosis | Leung CC | 2012 | 34.53 | 2013 | 2017 | ![]() |
| 5 | Silica induces NLRP3 inflammasome activation in human lung epithelial cells | Peeters PM | 2013 | 7.41 | 2013 | 2018 | ![]() |
| 6 | Silica: A lung carcinogen | Steenland K | 2014 | 10.81 | 2015 | 2019 | ![]() |
| 7 | A mechanistic review of silica-induced inhalation toxicity | Kawasaki H | 2015 | 9.33 | 2016 | 2020 | ![]() |
| 8 | Silica, Silicosis, and Autoimmunity | Pollard KM | 2016 | 17.76 | 2017 | 2021 | ![]() |
| 9 | Macrophage-derived MCPIP1 mediates silica-induced pulmonary fibrosis via autophagy | Liu HJ | 2016 | 10.44 | 2017 | 2021 | ![]() |
| 10 | Cell-Based Therapy for Silicosis | Lopes-Pacheco M | 2016 | 7.61 | 2017 | 2021 | ![]() |
| 11 | BBC3 in macrophages promoted pulmonary fibrosis development through inducing autophagy during silicosis | Liu HJ | 2017 | 10.84 | 2018 | 2021 | ![]() |
| 12 | Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis | Liu Y | 2017 | 7.33 | 2018 | 2019 | ![]() |
| 13 | Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice | Li C | 2017 | 10.07 | 2019 | 2022 | ![]() |
| 14 | Dioscin Alleviates Crystalline Silica-Induced Pulmonary Inflammation and Fibrosis through Promoting Alveolar Macrophage Autophagy | Du ST | 2019 | 8.58 | 2020 | 2023 | ![]() |
| 15 | Artificial stone-associated silicosis: a rapidly emerging occupational lung disease | Hoy RF | 2018 | 7.14 | 2020 | 2023 | ![]() |
| 16 | Silica-related diseases in the modern world | Hoy RF | 2020 | 19.91 | 2022 | 2025 | ![]() |
| 17 | Silica-associated lung disease: An old-world exposure in modern industries | Barnes H | 2019 | 14.90 | 2022 | 2025 | ![]() |
| 18 | Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages | Song MY | 2022 | 8.12 | 2022 | 2025 | ![]() |
| 19 | Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2 | Pang JL | 2021 | 7.64 | 2022 | 2025 | ![]() |
| 20 | Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017 | Shi P | 2020 | 7.13 | 2022 | 2023 | ![]() |
| 21 | New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis | Adamcakova J | 2021 | 15.80 | 2023 | 2025 | ![]() |
| 22 | Current global perspectives on silicosis—Convergence of old and newly emergent hazards | Hoy RF | 2022 | 9.45 | 2023 | 2025 | ![]() |
| 23 | Early Identification, Accurate Diagnosis, and Treatment of Silicosis | Tian L | 2022 | 9.45 | 2023 | 2025 | ![]() |
| 24 | Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration | Wang MY | 2022 | 8.77 | 2023 | 2025 | ![]() |
| 25 | Silicosis: An Update and Guide for Clinicians | Krefft S | 2020 | 7.33 | 2023 | 2025 | ![]() |
| [1] |
Leung CC, Ignatius TSY, Chen WH, et al. Silicosis. Lancet, 2012, 379(9830):2008-2018. doi:10.1016/S0140-6736(12)60235-9.
pmid: 22534002 |
| [2] | 中华预防医学会劳动卫生与职业病分会职业性肺部疾病学组, 同济大学附属上海市肺科医院, 四川大学华西第四医院, 等. 尘肺病治疗中国专家共识(2024年版). 环境与职业医学, 2024, 41(1):1-21. doi:10.11836/JEOM23379. |
| [3] | Handra CM, Gurzu IL, Chirila M, et al. Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease. Front Biosci (Landmark Ed), 2023, 28(5):96. doi:10.31083/j.fbl2805096. |
| [4] | Raanan R, Zack O, Ruben M, et al. Occupational Silica Exposure and Dose-Response for Related Disorders-Silicosis, Pulmonary TB, AIDs and Renal Diseases: Results of a 15-Year Israeli Surveillance. Int J Environ Res Public Health, 2022, 19(22):15010. doi:10.3390/ijerph192215010. |
| [5] | 刘智, 罗长春, 李超, 等. 1990—2021年中国矽肺疾病负担研究. 公共卫生与预防医学, 2024, 35(6):16-20. doi:10.3969/j.issn.1006-2483.2024.06.004. |
| [6] | GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990—2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440):2133-2161. doi:10.1016/S0140-6736(24)00757-8. |
| [7] | 袁方, 孟诗迪, 吴梦云, 等. 中国人群矽肺的疾病负担分析及预测探讨. 中国工业医学杂志, 2024, 37(6):551-554,666. doi:10.13631/j.cnki.zggyyx.2024.06.001. |
| [8] |
Chen C. CiteSpaceII: Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Tec, 2006, 57(3):359-377. doi.org/10.1002/asi.20317.
doi: 10.1002/asi.v57:3 URL |
| [9] |
Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 2010, 84(2):523-538. doi:10.1007/s11192-009-0146-3.
pmid: 20585380 |
| [10] |
Kirby T. Australia reports on audit of silicosis for stonecutters. Lancet, 2019, 393(10174):861. doi:10.1016/S0140-6736(19)30478-7.
pmid: 30837133 |
| [11] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr Eval Carcinog Risks Hum, 2010, 94:v-vii, 1-412. |
| [12] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Arsenic, metals, fibres, and dusts. IARC Monogr Eval Carcinog Risks Hum, 2012, 100(Pt C):11-465. |
| [13] |
Wu N, Xue C, Yu S, et al. Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis. Respirology, 2020, 25(5):518-524. doi:10.1111/resp.13744.
pmid: 31828940 |
| [14] | Rumchev K, Hoang DV, Lee A. Case Report: Exposure to Respirable Crystalline Silica and Respiratory Health Among Australian Mine Workers. Front Public Health, 2022, 10:798472. doi:10.3389/fpubh.2022.798472. |
| [15] | Yang B, Liu X, Peng C, et al. Silicosis: from pathogenesis to therapeutics. Front Pharmacol, 2025, 16:1516200. doi:10.3389/fphar.2025.1516200. |
| [16] |
Leung CC, Yew WW, Law WS, et al. Smoking and tuberculosis among silicotic patients. Eur Respir J, 2007, 29(4):745-750. doi:10.1183/09031936.00134706.
pmid: 17182648 |
| [17] |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012, 149(5):1060-1072. doi:10.1016/j.cell.2012.03.042.
pmid: 22632970 |
| [18] | Căluţu IM, Smărăndescu RA, Raşcu A. Biomonitoring Exposure and Early Diagnosis in Silicosis: A Comprehensive Review of the Current Literature. Biomedicines, 2022, 11(1):100. doi:10.3390/biomedicines11010100. |
| [19] | Jiang PR, Cao Z, Qiu ZL, et al. Plasma levels of TNF-α and MMP-9 in patients with silicosis. Eur Rev Med Pharmacol Sci, 2015, 19(9):1716-1720. |
| [20] |
Liu J, Song HY, Zhu BL, et al. The Effect of Silica Dust Exposure on the Serum Clara Cell Protein 16 Levels in Chinese Workers. Biomed Environ Sci, 2019, 32(1):47-50. doi:10.3967/bes2019.007.
pmid: 30696540 |
| [21] | Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis, 1993, 148(3):637-642. doi:10.1164/ajrccm/148.3.637. |
| [22] | Ohshimo S, Yokoyama A, Hattori N, et al. KL-6, a human MUC 1 mucin, promotes proliferation and survival of lung fibroblasts. Biochem Biophys Res Commun, 2005, 338(4):1845-1852. doi:10.1016/j.bbrc.2005.10.144. |
| [23] | Yu Q, Fu G, Lin H, et al. Influence of silica particles on mucociliary structure and MUC5B expression in airways of C57BL/ 6 mice. Exp Lung Res, 2020, 46(7):217-225. doi:10.1080/01902148.2020.1762804. |
| [24] |
Pingle SK, Thakkar LR, Jawade AA, et al. Neopterin: A candidate biomarker for the early assessment of toxicity of aluminum among bauxite dust exposed mine workers. Indian J Occup Environ Med, 2015, 19(2):102-109. doi:10.4103/0019-5278.165332.
pmid: 26500413 |
| [25] | Ma Z, Zhao C, Chen Q, et al. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo. Pulm Pharmacol Ther, 2018, 53:100-106. doi:10.1016/j.pupt.2018.10.006. |
| [26] | Su W, Liang Y, Meng Z, et al. Inhalation of Tetrandrine-hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment. Mol Pharm, 2020, 17(5):1596-1607. doi:10.1021/acs.molpharmaceut.0c00026. |
| [27] | Chen MH, Chen JC, Tsai CC, et al. Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats. Am J Chin Med, 2004, 32(2):195-207. doi:10.1142/S0192415X04001862. |
| [28] | Li H. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. J Ethnopharmacol, 2020, 251:112442. doi:10.1016/j.jep.2019.112442. |
| [29] |
Zhang E, Yang Y, Chen S, et al. Bone marrow mesenchymal stromal cells attenuate silica-induced pulmonary fibrosis potentially by attenuating Wnt/β-catenin signaling in rats. Stem Cell Res Ther, 2018, 9(1):311. doi:10.1186/s13287-018-1045-4.
pmid: 30428918 |
| [30] | Skibba M, Drelich A, Poellmann M, et al. Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis. Front Pharmacol, 2020, 11:607689. doi:10.3389/fphar.2020.607689. |
| [1] | Feng Yi, Chang Qing, Li Feng. Research progress of combined pulmonary fibrosis and emphysema [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(5): 425-431. |
| [2] | Chen Zidan, Mao Ling. Clinical analysis of 28 cases of artificial stone associated silicosis complicated with pulmonary tuberculosis and non-tuberculous mycobacteria disease [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(5): 388-393. |
| [3] | ZHOU Lei, LUO Li, LU Zhi-bin, DING Yan, XIAO Yang-bao. Mechanism of rapamycin target protein/autophagy signaling pathway in tuberculous tracheal bronchial stenosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(2): 137-141. |
| [4] | SUN Ming-lei, GUAN Li, LIANG Li-bo, ZHAO Juan, WANG Chen, ZOU Dan-dan. Bibliometric analysis of tuberculosis patient and care system delay based on Web of Science core database [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 62-68. |
| [5] | Jian-jun MA,Yan-li YUAN,Tie-juan ZHANG. Visual citation analysis on co-morbid tuberculosis and diabetes mellitus publications based on the Web of Science [J]. Journal of Tuberculosis and Lung Health, 2018, 7(3): 198-204. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公安网备11010202008787号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.